EVGN

Evogene Ltd.

Latest Form 4:Purchase$677byTarcic Gabi (Chief Development Officer) · filed Aug 26, 2026

Evogene Ltd. (EVGN) has 3 SEC Form 4 filings (3 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Aug 26, 2026.

Insiders have net bought $693K over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Ofer Haviv
  • Employees:52
  • HQ:Rehovot, HM, IL
  • IPO:2010-10-15

Insider Buying

$693K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Market Cap

$4.8M

Price slightly stale

Source
Tarcic GabiFirst filing
Purchase$677Aug 26SEC ↗
Purchase$292KAug 13SEC ↗
RECANATI LEONFirst filing
Purchase$400KAug 5SEC ↗

Related companies

Evogene Ltd. is in the Manufacturing sector.